New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down’s syndrome. Despite children with Down’s syndrome having around a one in 50 chance of developing acute myeloid leukaemia (AML), compared to a one